Novel NMDA Receptor Antagonist Wins for Major Depression

(MedPage Today) -- An investigational N-methyl-D-aspartate (NMDA)-receptor antagonist was effective at treating major depressive disorder in the phase III GEMINI trial.
The 1:1 randomized controlled study of 327 adults with major depression found...